Sodium Bicarbonate Injection — FDA Drug Shortage

Current — Amphastar Pharmaceuticals, Inc.

The FDA lists a drug shortage record for Sodium Bicarbonate Injection (injection) from Amphastar Pharmaceuticals, Inc. with status Current. The shortage was first posted on Mar 1, 2017. Reported reason: Demand increase for the drug

Shortage details

Status
Current
Company
Amphastar Pharmaceuticals, Inc.
Package NDC
76329-3352-1
Dosage Form
Injection
Presentation
Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 76329-3352-1)
Initial Posting
Mar 1, 2017

Reason

Demand increase for the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.